Bart Van Acker is the Founder / Managing Director at QbD Group. Bart also holds positions as a Board Member at Qarad, TRIUM Clinical Consulting NV, Quercus Labo, and H2M - Health to Market. Additionally, Bart is a Co-Founder at Scilife, simAbs, Persomed life sciences, and PILS Group. Bart is also a Founder at H2M - Health to Market. Furthermore, Bart serves as a Member of the Board at FlandersBio. Bart Van Acker studied Bio-Engineer, Genetic biotechnology at KU Leuven from 1998 to 2003.
Sign up to view 5 direct reports
Get started